solid tumors

First-in-human Study of Next-generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors

CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI: Harbour BioMed (HBM) today announced the start of the first clinical trial…